Helicobacter pylori l-asparaginase: A promising chemotherapeutic agent

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1222-1226

  Cappelletti, Donata ^a   Chiarelli, Laurent R ^a   Pasquetto, Maria Valentina ^a   Stivala, Simona ^a   Valentini, Giovanna ^a   Scotti, Claudia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Biochemical characterisation; Chemotherapeutic agent; Cloning; Cytotoxicity; Helicobacter pylori; l Asparaginase

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; GLUTAMINE; RECOMBINANT ENZYME; BACTERIAL PROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME STABILITY; ENZYMOLOGY; GENETICS; IC 50; PH; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; BACTERIAL PROTEINS; CELL LINE, TUMOR; CLONING, MOLECULAR; ENZYME STABILITY; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; MODELS, MOLECULAR;

EID: 56349132710     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.118     Document Type: Article

References (36)

1. Michalska K., and Jaskolski M. Structural aspects of l-asparaginases, their friends and relations. Acta Biochim. Pol. 53 (2006) 627-640
2. Sanches M., Krauchenco K., and Polikarpov I. Structure, substrate complexation and reaction. Mechanism of bacterial asparaginases. Curr. Chem. Biol. 1 (2007) 75-86
3. Yun M.K., Nourse A., White S.W., Rock C.O., and Heath R.J. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli l-asparaginase I. J. Mol. Biol. 369 (2007) 794-811
4. Aghaiypour K., Wlodawer A., and Lubkowski J. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi l-asparaginase. Biochemistry 40 (2001) 5655-5664
5. Swain A.L., Jaskolski M., Housset D., Rao J.K., and Wlodawer A. Crystal structure of Escherichia coli l-asparaginase, an enzyme used in cancer therapy. Proc. Natl. Acad. Sci. USA 90 (1993) 1474-1478
6. Lubkowski J., Palm G.J., Gilliland G.L., Derst C., Rohm K.H., and Wlodawer A. Crystal structure and amino acid sequence of Wolinella succinogenes l-asparaginase. Eur. J. Biochem. 241 (1996) 201-207
7. Dodson G., and Wlodawer A. Catalytic triads and their relatives. Trends Biochem. Sci. 23 (1998) 347-352
8. Moola Z.B., Scawen M.D., Atkinson T., and Nicholls D.J. Erwinia chrysanthemi l-asparaginase: epitope mapping and production of antigenically modified enzymes. Biochem J. 302 Pt. 3 (1994) 921-927
9. Keating M.J., Holmes R., Lerner S., and Ho D.H. l-Asparaginase and PEG asparaginase-past, present, and future. Leuk. Lymphoma 10 Suppl. (1993) 153-157
10. Reinert R.B., Oberle L.M., Wek S.A., Bunpo P., Wang X.P., Mileva I., Goodwin L.O., Aldrich C.J., Durden D.L., McNurlan M.A., Wek R.C., and Anthony T.G. Role of glutamine depletion in directing tissue-specific nutrient stress responses to l-asparaginase. J. Biol. Chem. 281 (2006) 31222-31233
11. Distasio J.A., Salazar A.M., Nadji M., and Durden D.L. Glutaminase-free asparaginase from Vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity. Int. J. Cancer 30 (1982) 343-347
12. Ollenschlager G., Roth E., Linkesch W., Jansen S., Simmel A., and Modder B. Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects. Eur. J. Clin. Invest. 18 (1988) 512-516
13. Gallagher M.P., Marshall R.D., and Wilson R. Asparaginase as a drug for treatment of acute lymphoblastic leukaemia. Essays Biochem. 24 (1989) 1-40
14. Ferreira A.C., Isomoto H., Moriyama M., Fujioka T., Machado J.C., and Yamaoka Y. Helicobacter and gastric malignancies. Helicobacter 13 Suppl. 1 (2008) 28-34
15. Tippmann H.F. Analysis for free: comparing programs for sequence analysis. Brief Bioinform. 5 (2004) 82-87
16. Myers E.W., and Miller W. Optimal alignments in linear space. Comput. Appl. Biosci. 4 (1988) 11-17
17. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
18. Wriston Jr. J.C., and Yellin T.O. l-Asparaginase: a review. Adv. Enzymol. Relat. Areas Mol. Biol. 39 (1973) 185-248
19. Balcao V.M., Mateo C., Fernandez-Lafuente R., Malcata F.X., and Guisan J.M. Structural and functional stabilization of l-asparaginase via multisubunit immobilization onto highly activated supports. Biotechnol. Prog. 17 (2001) 537-542
20. Lambert C., Leonard N., De Bolle X., and Depiereux E. ESyPred3D: prediction of proteins 3D structures. Bioinformatics 18 (2002) 1250-1256
21. Boeckmann B., Bairoch A., Apweiler R., Blatter M.C., Estreicher A., Gasteiger E., Martin M.J., Michoud K., O'Donovan C., Phan I., Pilbout S., and Schneider M. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 31 (2003) 365-370
22. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., and Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
23. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 57 (2001) 122-133
24. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
25. Sippl M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 17 (1993) 355-362
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
27. Kotzia G.A., and Labrou N.E. l-Asparaginase from Erwinia chrysanthemi 3937: cloning, expression and characterization. J. Biotechnol. 127 (2007) 657-669
28. Ho P.P., and Milikin E.B. Multiple forms of l-asparaginase. Biochim. Biophys. Acta 206 (1970) 196-198
29. Howard J.B., and Carpenter F.H. l-Asparaginase from Erwinia carotovora. Substrate specificity and enzymatic properties. J. Biol. Chem. 247 (1972) 1020-1030
30. Krasotkina J., Borisova A.A., Gervaziev Y.V., and Sokolov N.N. One-step purification and kinetic properties of the recombinant l-asparaginase from Erwinia carotovora. Biotechnol. Appl. Biochem. 39 (2004) 215-221
31. Derst C., Henseling J., and Rohm K.H. Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248. Protein Sci. 9 (2000) 2009-2017
32. Ho P.P., Milikin E.B., Bobbitt J.L., Grinnan E.L., Burck P.J., Frank B.H., Boeck L.D., and Squires R.W. Crystalline l-asparaginase from Escherichia coli B. I. Purification and chemical characterization. J. Biol. Chem. 245 (1970) 3708-3715
33. Stecher A.L., de Deus P.M., Polikarpov I., and Abrahao-Neto J. Stability of l-asparaginase: an enzyme used in leukemia treatment. Pharm. Acta Helv. 74 (1999) 1-9
34. Dhavala P., Krasotkina J., Dubreuil C., and Papageorgiou A.C. Expression, purification and crystallization of Helicobacter pylori l-asparaginase. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64 (2008) 740-742
35. Avramis V.I., and Tiwari P.N. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int. J. Nanomed. 1 (2006) 241-254
36. Bauerfeind P., and Wirth H.P. Peptic ulcer, Helicobacter pylori. Ther. Umsch. 54 (1997) 624-628